The European Council and Parliament have reached an agreement on the European Commission’s proposal to deregulate new GMOs.

A phase 1/2 clinical trial examining the CRISPR-engineered allogeneic chimeric antigen receptor (CAR)-T candidate AVC-203 (QUADvance) has been approved by the FDA and the European Medicines Agency ...

Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...

Doctors have now used a gene-edited pig liver to keep a human alive, not as a thought experiment in a lab but as a real ...